1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Shuda Xia
Shuda Xia
Articles (322) 

Weekly Top Insider Buys Highlight for the Week of July 19

The largest Insider Buys this week were for Fastenal Co., HealthEquity Inc., Hyster-Yale Materials Handling Inc. and NGM Biopharmaceuticals Inc.

July 21, 2019 | About:

The largest Insider Buys this week were for Fastenal Co. (NASDAQ:FAST), HealthEquity Inc. (NASDAQ:HQY), Hyster-Yale Materials Handling Inc. (NYSE:HY) and NGM Biopharmaceuticals Inc. (NASDAQ:NGM).

Fastenal Co. (NASDAQ:FAST): Director Michael J. Ancius bought 1,104 shares

Director Michael J. Ancius bought 1,104 shares of FAST stock on July 18 at the average price of $30.13. The price of the stock has increased by 0.8% since.

Fastenal Co. is an American international industrial supply company that focuses on distributing industrial, safety, and construction supplies. The company has over 2,600 branches throughout the United States, Canada, Mexico, and Canada. The company has a market capitalization of $17.42 billion, and as of July 19 it traded at $30.37.

On July 11 Fastenal Co. reported results for the second quarter of 2019 ended June 30. Net sales for the quarter was $1.368 billion, compared to net sales of $1.267 billion during the same quarter prior year. Gross profit for the quarter was $641.2 million, while gross profit was $617.7 million for the same quarter prior year.

HealthEquity Inc. (NASDAQ:HQY): Director Robert W. Selander bought 10,000 shares

Director Robert W. Selander bought 10,000 shares of HQY stock on July 12 at the average price of $61. The price of the stock has increased by 29.8% since.

HealthEquity Inc. is an American non-bank health savings trustee as designated by the IRS. The designation allows the company to manage health savings accounts regardless of which financial institution the funds are deposited with. The company has a market capitalization of $4.97 billion, and as of July 19 it traded at $79.18.

On July 12 HealthEquity Inc. announced the closing of the underwritten public offering of 7,762,500 shares of its common stock. The gross proceeds from the offering totaled $473.5 million and the company intends to use the net proceeds to fund the merger consideration for its pending acquisition with WageWorks Inc.

Hyster-Yale Materials Handling Inc. (NYSE:HY): Group Member Victoire G. Rankin bought 3,077 shares

Group Member Victoire G. Rankin bought 3,077 shares of HY stock on July 11 at the average price of $53.84. The price of the stock has decreased by 0.76% since.

Hyster-Yale Materials Handling Inc. is an American manufacturing company that focuses on designing, engineering, manufacturing, and selling a line of lift trucks and aftermarket parts. The company was spun off from NACCO Industries in 2012. Some of the company’s subsidiaries include Nuvera Fuel Cells and Bolzoni S.P.A. The company has a market capitalization of $889.94 million, and as of July 19 it traded at $53.43.

On May 17 Hyster-Yale Materials Handling Inc. announced that the Board of Directors has increased its regular cash dividend from $0.31 to $0.3175 per share. The dividend is payable for both the Class A and Class B common stock and was paid on June 14 to shareholders on record at the close of business on May 31.

NGM Biopharmaceuticals Inc. (NASDAQ:NGM): Director David V. Goeddel bought 20,088 shares

Director David V. Goeddel bought 20,088 shares of NGM stock on July 16 at the average price of $13.72. The price of the stock has increased by 2.26% since.

NGM Biopharmaceuticals Inc. is an American clinical stage biopharmaceutical company that focuses on the development of new therapeutics based on understanding of key biological pathways underlying cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company has a market capitalization of $926.3 million, and as of July 19 it traded at $14.03.

On May 16 NGM Biopharmaceuticals Inc. reported first quarter 2019 financial results for the period ended March 31. Revenue for the quarter was $25.6 million, compared to $1806 million during the same period prior year. Research and development expenses for the quarter were $29.5 million, compared to $19.5 million for the same period prior year.

For the complete list of stocks that were bought by their company executives, go to: Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Shuda Xia


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)